Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology

Critical Reviews in Neurobiology

Volumn 13, Issue 1, 1999, Pages 45-82

  O'Banion, M Kerry ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Alzheimer's disease; Glia; Hyperalgesia; Neurons; Nonsteroidal antiinflammatory drugs (NSAIDs); Phosphalipase A2; Prostaglandin; Seizure; Stroke

Indexed keywords

5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; FLOSULIDE; IBUPROFEN; INDOMETACIN; MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTANOID; ROFECOXIB; SALICYLIC ACID; SULFIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; CEREBROVASCULAR DISEASE; CYTOLOGY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERALGESIA; MOLECULAR BIOLOGY; NERVOUS SYSTEM; NEUROBIOLOGY; NEUROLOGIC DISEASE; PHARMACOLOGY; REVIEW; SLEEP PATTERN; STRESS;

EID: 0032896588     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevNeurobiol.v13.i1.30     Document Type: Review

References (354)

1. Smith, W. L., Prostanoid biosynthesis and mechanisms of action, Am. J. Physiol., 263, F181-F191, 1992.
2. 2 super-family of signal transduction enzymes, Trends Biochem. Sci., 22, 1-2, 1997.
3. 2, J. Biol. Chem., 272, 16709-16712, 1997.
4. 2, Crit. Rev. Immunol., 17, 225-283, 1997.
5. Miayamoto, T., Ogino, N., Yamamoto, S., and Hayaishi, O., Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes, J. Biol. Chem., 1976; 251: 2629-2636.
6. Hemler, M. E., Lands, W. E. M., and Smith, W. L., Purification of the cyclooxygenase that forms prostaglandins: demonstration of two forms of iron in the holoenzyme, J. Biol. Chem., 255, 5575-5579, 1976.
7. DeWitt, D. L. and Smith, W. L., Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence, Proc. Natl. Acad. Sci. U.S.A., 85, 1412-1416, 1988.
8. Merlie, J. P., Fagan, D., Mudd, J., and Needleman, P., Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase), J. Biol. Chem., 263, 3550-3553, 1988.
9. Yokayama, C., Takai, T., and Tanabe, T., Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequences, FEBS Lett., 231, 347-351, 1988.
10. O'Banion, M. K., Sadowski, H. B., Winn, V., and Young, D. A., A serum- and glucocorticoid-regulated 4 kb mRNA encodes a cyclooxygenase related protein, J. Biol. Chem., 266, 23261-23267, 1991.
11. Raz, A., Wyche, A., and Needleman, P., Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases, Proc. Natl. Acad. Sci. U.S.A., 86, 1657-1661, 1989.
12. v-src-transformed 3T3 fibroblasts, Proc. Natl. Acad. Sci. U.S.A., 87, 3373-3377, 1990.
13. 2 synthase (cyclooxygenase) in human monocytes, J. Biol. Chem., 265, 16737-16740, 1990.
14. Masferrer, J. L., Zweifel, B. S., Seilbert, K., and Needleman, P., Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice, J. Clin. Invest., 1990; 86, 1375-1379, 1990.
15. Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., and Herschmann, H. R., TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue, J. Biol. Chem., 266, 12866-12872, 1991.
16. Xie, W., Chipman, J. G., Robertson, D. L., Erikson, R. L., and Simmons, D. L., Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing, Proc. Natl. Acad. Sci. U.S.A., 88, 2692-2696, 1991.
17. O'Banion, M. K., Winn, V. D., and Young, D. A., cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase, Proc. Natl. Acad. Sci. U.S.A., 89, 4888-4892, 1992.
18. Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S., and Cerami, A., Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators, Proc. Natl. Acad. Sci. U.S.A., 83, 1670-1674, 1986.
19. Shaw, G. and Kamen, R., A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation, Cell, 1986; 46, 659-667, 1986.
20. Ristimäki, A., Narko, K., and Hla, T., Downregulation of cytokine-induced cyclooxygenase-2 transcript isoforms by dexamethasone: evidence for posttranscriptional regulation, Biochem. J., 318, 325-331, 1996.
21. Ristimäki, A., Garfinkel, S., Wessendorf, J., Maciag, T., and Hla, T., Induction of cyclooxygenase-2 by interleukin-1α. Evidence for posttranscriptional regulation, J. Biol. Chem., 269, 11769-11775, 1994.
22. Srivastava, S. K., Tetsuka, T., Daphna-Iken, D., and Morrison, A. R., IL-1β stabilizes COX II mRNA in renal mesangial cells: role of 3′-untranslated region, Am. J. Physiol., 267, F504-F508, 1994.
23. Munro, S., and Pelham, H. R. B., A C-terminal signal prevents secretion of luminal ER proteins, Cell, 48, 899-907, 1987.
24. Song, I. and Smith, W. L., C-terminal ser/pro-thr-glu-leu tetrapeptides of prostaglandin endoperoxide H synthases-1 and -2 target the enyzmes to the endoplasmic reticulum, Arch. Biochem. Biophys., 334, 67-72, 1996.
25. Otto, J. C., DeWitt, D. L., and Smith, W. L., N-glycosylation of prostaglandin endoperoxide syntheses-1 and - 2 and their orientations in the endoplasmic reticulum, J. Biol. Chem., 268, 18234-18242, 1993.
26. Picot, D., Loll, P. J., and Garavito, R. M., The X-ray crystal structure of the membrane protein prostaglandin H synthase-1, Nature, 367, 243-249, 1994.
27. Luong, C., Miller, A., Barnett, J., Chow, J., Ramesha, C., and Browner, M. F., Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2, Nature Struc. Biol., 3, 927-933, 1996.
28. Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., Miyashiro, J. M., Penning, T. D., Seibert, K., Isakson, P. C., and Stallings, W. C., Structural basis for selective inhibition of cyclooxygenase-2 by antiinflammatory agents, Nature, 384, 644-648, 1996.
29. Regier, M. K., DeWitt, D. L., Schindler, M. S., and Smith, W. L., Subcellular localization of prostaglandin endoperoxide synthase-2 in murine 3T3 cells, Arch. Biochem. Biophys., 301, 439-444, 1993.
30. Morita, I., Schindler, M., Regier, M. K., Otto, J. C., Hori, T., DeWitt, D. L., and Smith, W. L., Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2, J. Biol. Chem., 270, 10902-10908, 1995.
31. Smith, W. L., DeWitt, D. L., Arakawa, T., Spencer, A. G., Thuresson, E. D., and Song, I., Independent prostanoid biosynthetic systems associated with prostaglandin endoperoxide syntheses-1 and -2, Thromb. Hemostasis, 78, 627-630, 1997.
32. Spencer, A. G., Woods, J. W., Arakawa, T., Singer, I. I., and Smith, W. L., Subcellular localization of prostaglandin endoperoxide H syntheses-1 and -2 by immunoelectron microscopy, J. Biol. Chem., 273, 9886-9893, 1998.
33. Kaufmann, W. E., Worley, P. F., Pegg, J., Bremer, M., and Isakson, P., Cox-2, a synaptically-induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex, Proc. Natl. Acad. Sci. U.S.A., 93, 2317-2321, 1996.
34. Fletcher, B. S., Kujubu, D. A., Perrin, D. M., and Herschmann, H. R., Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase, J. Biol. Chem., 267, 4338-4344, 1992.
35. Tazawa, R., Xu, X. M., Wu, K. K., and Wang, L. H., Characterization of the genomic structure, chromosomal location, and promoter of human prostaglandin H synthase-2 gene, Biochem. Biophys. Res. Comm., 203, 190-199, 1994.
36. Sirois, J., Levy, L. O., Simmons, D. L., and Richards, J. S., Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells, J. Biol. Chem., 268, 12199-12206, 1993.
37. Yokoyama, C. and Tanabe, T., Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme, Biochem. Biophys. Res. Comm., 165, 888-894, 1989.
38. Kraemer, S. A., Meade, E. A., and DeWitt, D. L., Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5′-flanking regulatory sequences, Arch. Biochem. Biophys., 293, 391-400, 1992.
39. Kujubu, D. A. and Herschmann, H. R., Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene, J. Biol. Chem., 267, 7991-7994, 1992.
40. Onoe, Y., Miyaura, C., Kaminakayashiki, T., Nagai, T., Noguchi, K., et al., IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts, J. Immunol., 156, 758-764, 1996.
41. Vane, J. R., Bakhle, Y. S., and Botting, R. M., Cyclooxygenases 1 and 2, Annul. Rev. Pharmocol. Toxicol., 38, 97-120, 1998.
42. Herschman, H. R., Prostaglandin synthase 2, Biochim. Biophys. Acta, 1299, 125-140, 1996.
43. Herschman, H. R., Reddy, S. T., and Xie, W., Function and regulation of prostaglandin synthase-2, Adv. Exp. Med. Biol., 407, 61-66, 1997.
44. Pairet, M. and Engelhardt, G., Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications, Fund. Clin. Pharmacol., 10, 1-17, 1996.
45. Smith, W. L., Garavito, R. M., and DeWitt, D. L., Prostaglandin endoperoxide H syntheses cyclooxygenases-1 and -2, J. Biol. Chem., 271, 33157-33160, 1996.
46. Smith, W. L. and Dewitt, D. L., Prostaglandin endoperoxide H synthases-1 and -2, Adv. Immunol., 62, 167-215, 1996.
47. Williams, C. S. and DuBois, R. N., Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol., 270, G393-G400, 1996.
48. Xie, W. and Herschman, H. R., Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum, J. Biol. Chem., 271, 31742-31748, 1996.
49. Xie, W. and Herschmann, H. R., v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor, J. Biol. Chem., 270, 27622-27628, 1995.
50. Yamamoto, K., Arakawa, T., Ueda, N., and Yamamoto, S., Transcriptional roles of nuclear factor κB and nuclear factor interleukin-6 in the tumor necrosis alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells, J. Biol. Chem., 270, 31315-31320, 1995.
51. Morris, J. K. and Richards, J. S., An E-box region within the prostaglandin endoperoxide synthase-2 (PGS-2) promoter is required for transcription in rat ovarian granulosa cells, J. Biol. Chem., 271, 16633-16643, 1996.
52. Bazan, N. G., Fletcher, B. S., Herschmann, H. R., and Mukherjee, P. K., Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene, Proc. Natl. Acad. Sci. U.S.A., 91, 5252-5256, 1994.
53. Newton, R., Kuitert, L. M. E., Bergmann, M., Adcock, I. M., and Barnes, P. J., Evidence for involvement of NF-κB in the transcriptional control of COX-2 gene expression by IL-1β, Biochem. Biophys. Res. Comm., 237, 28-32, 1997.
54. Ridley, S. H., Sarsfield, S. J., Lee, J. C., Bigg, H. F., Cawston, T. E., Taylor, D. J., DeWitt, D. L., and Saklatvala, J., Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels, J. Immunol., 158, 3165-3173, 1997.
55. Niho, Y., Niiro, H., Tanaka, Y., Nakashima, H., and Otsuka, T., Role of IL-10 in the crossregulation of prostaglandins and cytokines in monocytes, Acta Haematologica, 99, 165-170, 1998.
56. 2) production by normal human polymorphonuclear neutrophils by enhancing cyclooxygenase 2 (COX-2) gene expression, Inflamm. Res., 47, 167-173, 1998.
57. Zakar, T., Hirst, J. J., Mijovic, J. E., and Olson, D. M., Glucocorticoids stimulate the expression of prostaglandin endoperoxide H synthase-2 in amnion cells, Endocrinology, 136, 1610-1619, 1995.
58. Goppelt-Struebe, M., Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids, Biochem. Pharmacol., 53, 1389-1395, 1997.
59. Wallace, A. D., Wheeler, T. T., and Young, D. A., Inducibility of E4BP4 suggests a novel mechanism of negative gene regulation by glucocorticoids, Biochem. Biophys. Res. Comm., 232, 403-406, 1997.
60. Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., DuBois, R. N., and Breyer, M. D., Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction, J. Clin. Invest., 1994; 94, 2504-2510, 1994.
61. Yamagata, K., Andreasson, K. I., Kaufmann, W. L, Barnes, C. A., and Worley, P. F., Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids, Neuron, 11, 371-386, 1993.
62. 2, J. Biol. Chem., 268, 839-844, 1993.
63. 2 by rat mesangial cells: its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells, J. Clin. Invest., 2516-2523, 1993.
64. 2, J. Biol. Chem., 95, 7951-7956, 1998.
65. 2 and distal prostaglandin synthase, J. Biol. Chem., 271, 186-191, 1996.
66. 2 in mouse bone marrow-derived mast cells, J. Biol. Chem., 269, 22269-22275, 1994.
67. 2 generation via prostaglandin endoperoxide synthase-2, J. Immunol., 155, 4445-4453, 1995.
68. 2 production in mast cells, J. Immunol., 155, 818-825, 1995.
69. 2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis, J. Biol. Chem., 269, 25999-26005, 1994.
70. 2 to the nuclear fraction upon macrophage activation, Biochem. Biophys. Res. Commun., 196, 147-153, 1993.
71. 2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/anti-gen, J. Biol. Chem., 270, 15359-15367, 1995.
72. 2 to the nuclear envelope and endoplasmic reticulum, J. Biol. Chem., 270, 30749-30754, 1995.
73. 2 genes in embryonic mouse cells, J. Biol. Chem., 269, 21786-21792, 1994.
74. 2 and cyclooxygenase-2, Eur. J. Biochem., 226, 125-131, 1994.
75. 2 in rat cultured astrocytes, J. Biol. Chem., 266, 9956-9960, 1991.
76. O'Banion, M. K., Dusel, J. C., Miller, D. K., and Coleman, P. D., Regulation of a novel cyclooxygenase (prostaglandin G/H synthase) gene by dexamethasone and calcium ionophore in astrocytes, Soc. Neurosci. Abstr., 18, 1449, 1992.
77. Nathan, C. and Xie, Q.-W., Regulation of biosynthesis of nitric oxide, J. Biol. Chem., 269, 13725-13728, 1994.
78. Xie, Q.-W., Whisnaut, R., and Nathan, C., Promoter of the mouse gene encoding calcium-independent NO synthase confers inducibility by interferon γ and bacterial lipopolysaccharide, J. Exp. Med., 177, 1779-1784, 1993.
79. Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., and Murphy, W. J., Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide, Proc. Natl. Acad. Sci. U.S.A., 90, 9730-9734, 1993.
80. Radomski, M. W., Palmer, R. M. J., and Moncada, S., Glucocorticoids inhibit the expression of an inducible but not the constitutive NO synthase in vascular endothelial cells, Proc. Natl. Acad. Sci. U.S.A., 87, 10043-10047, 1990.
81. Szabó, C., Theimermann, C., Wu, C.-C., Rerretti, M., and Vane, J. R., Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo, Proc. Natl. Acad. Sci. U.S.A., 91, 271-275, 1994.
82. Gazzinelli, R. T., Oswald, I. P., James, S. L., and Sher, A., IL-10 inhibits cell killing and nitrogen oxide production by IFN-gamma-activated macrophages, J. Immunol., 148, 1792-1796, 1992.
83. Vane, J. R., Mitchell, J. A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J., and Willoughby, D. A., Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation, Proc. Natl. Acad. Sci. U.S.A., 91, 2046-2050, 1994.
84. Swierkosz, T. A., Mitchell, J. A., Warner, T. D., Botting, R. M., and Vane, J. R., Coinduction of nitric oxide synthase and cyclooxygenase: interactions between nitric oxide and prostanoids, Br. J. Pharmacol., 114, 1335-1342, 1995.
85. Beckmann, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M., and White, C. R., Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry, Biol. Chem. Hoppe-Seyler, 375, 81-88, 1994.
86. Dawson, V. L. and Dawson, T. M., Nitric oxide neurotoxicity, J. Chem. Neuroanat., 10, 179-190, 1996.
87. 2 release from the hypothalamus, Proc. Natl. Acad. Sci. U.S.A., 89, 11543-11546, 1992.
88. Corbett, J. A., Kwon, G., Turk, J., and McDaniel, M. L., IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide, Biochemistry, 32, 13767-13770, 1993.
89. Franchi, A. M., Chaud, M., Rettori, V., Suburo, A., McCann, S. M., and Gimeno, M., Role of nitric oxide in eicosanoid synthesis and uterine motility in estrogen-treated rat uteri, Proc. Natl. Acad. Sci. U.S.A., 91, 539-543, 1994.
90. Davidge, S. T., Baker, P. N., McLaughlin, M. K., and Roberts, J. M., Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase, Circ. Res., 77, 274-283, 1995.
91. Salvemini, D., Misko, T. P., Masferrer, J. L., Seibert, K., Currie, M. G., and Needleman, P., Nitric oxide activates cyclooxygenase enzymes, Proc. Natl. Acad. Sci. U.S.A., 90, 7240-7244, 1993.
92. Landino, L. M., Crews, B. C., Timmons, M. D., Morrow, J. D., and Marnett, L. J., Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis, Proc. Natl. Acad. Sci. U.S.A., 93, 15069-15074, 1996.
93. Stadler, J., Harbrecht, B. G., Di Silvio, M., Curran, R. D., Jordan, M. L., Simmons, R. L., and Billiar, T. R., Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells, J. Leukoc. Biol., 53, 165-172, 1993.
94. 2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774, Prostaglandins, 49, 105-115, 1995.
95. Stratman, N. C., Carter, D. B., and Sethy, V. H., Ibuprofen: effect on inducible nitric oxide synthase, Mol. Brain Res., 50, 107-112, 1997.
96. Aeberhard, E. E., Henderson, S. A., Arabolow, N. S., Griscavage, J. M., Castro, F. E., Barrett, C. T., and Ignarro, L. J., Nonsteroidal antiinflammatory drugs inhibit expression of the inducible nitric oxide synthase gene, Biochem. Biophys. Res. Comm., 208, 1053-1059, 1995.
97. Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., and Smithies, O., Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse, Cell, 83, 473-482, 1995.
98. Dinchuk, J. E., Car, B. D., Focht, R. J., Johnston, J. J., Jaffee, B. D., Covington, M. B., Contel, N. R., Eng, V. M., Collins, R. J., Czerniak, P. M., Gorry, S. A., and Trzaskos, J. M., Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II, Nature, 378, 406-409, 1995.
99. Li, S., Wang, Y., Matsumura, K., Ballon, L., Morham, S. G., and Blatteis, C. M., The febrile response to lipopolysaccharide (LPS) is blocked in COX-2-/-but not COX-1-/-mice, Soc. Neurosci. Abstr., 24, 367, 1998.
100. 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2), Cell, 87, 803-809, 1996.
101. Lim, H., Paria, B. C., Das, S. K., Dinchuk, J. E., Langenbach, R., Trzaskos, J. M., and Dey, S. K., Multiple female reproductive failures in cyclooxygenase 2-deficient mice, Cell, 91, 197-208, 1997.
102. Sirois, J., Simmons, D. L., and Richards, J. S., Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat preovulatory follicles, J. Biol. Chem., 267, 11586-11592, 1992.
103. Sirois, J., Induction of prostaglandin endoperoxide H synthase-2 by human chorionic gonadotrophin in bovine preovulatory follicles, Endocrinology, 135, 841-848, 1994.
104. Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., Kim, H. S., and Smithies, O., Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration, Cell, 83, 483-492, 1995.
105. Sugimoto, Y., Yamasaki, A., Segi, E., Tsuboi, K., Aze, Y., Nishimura, T., Oida, H., Yoshida, N., Tanaka, T., Katsuyama, M., Hasumoto, K.-Y., Murata, T., Hirata, M., Ushikubi, F., Negishi, M., Ichikawa, A., and Narumiya, S., Failure of parturition in mice lacking the prostaglandin F receptor, Science, 277, 681-683, 1997.
106. 2 in brain cell and tissue injury associated with ischemia and excitotoxicity, J. Lipid Mediat. Cell Signal., 16, 199-208, 1997.
107. Challis, J. R., Prostaglandins and reproduction -what do knockouts really tell us? [news], Nature Med., 3, 1326-1327, 1997.
108. Crofford, L. J., Wilder, R. L., Ristimäki, A. P., Sano, H., Remmers, E. F., Epps, H. R., and Hla, T., Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-1β, phorbol ester, and corticosteroids, J. Clin. Invest., 93, 1095-1101, 1994.
109. Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C., and Gregory, S. A., Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin-6 in rat adjuvant arthritis, J. Clin. Invest., 97, 2672-2679, 1996.
110. 2: distinct roles of cyclooxygenase-1 and -2, J. Biol. Chem., 272, 25693-25699, 1997.
111. 2 induces interleukin-6 synthesis in human astrocytoma cells, J. Neurochem., 68, 704-709, 1997.
112. 2 in a murine model of inflammation: possible role of cyclooxygenase-2, Proc. Natl. Acad. Sci. U.S.A., 93, 4885-4890, 1996.
113. Mertz, P. M., DeWitt, D. L., Stetler-Stevenson, W. G., and Wahl, L. M., Interleukin-10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production, J. Biol. Chem., 269, 21322-21329, 1994.
114. 2, J. Biol. Chem., 268, 10364-10371, 1993.
115. 2 blocks inflammation, hyperalgesia, and interleukin-6 production in vivo, J. Exp. Med., 184, 883-891, 1996.
116. Futaki, N., Arai, I, Hamasaka, Y., Takahashi, S., Higuchi, S., and Otomo, S., Selective inhibition of NS-398 on prostanoid production in inflammed tissue in rat carrageenan-air-pouch inflammation, J. Pharm. Pharmacol., 45, 753-755, 1993.
117. Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., and Seibert, K., Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic, Proc. Natl. Acad. Sci. U.S.A., 91, 3228-3232, 1994.
118. Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., and Isakson, P. C., Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain, Proc. Natl. Acad. Sci. U.S.A., 91, 12013-12017, 1994.
119. Masaki, M., Matsushita, M., and Wakitani, K., Inhibitory effects of JTE-522, a novel prostaglandin H synthase-2 inhibitor, on adjuvant-induced arthritis and bone changes in rats, Inflamm. Res., 47, 187-192, 1998.
120. Lane, N. E., Pain management in osteoarthritis: the role of COX-2 inhibitors, J. Rheumatol., 24 (Suppl. 49): 20-24, 1997.
121. Lipsky, P. E. and Isakson, P. C., Outcome of specific COX-2 inhibition in rheumatoid arthritis, J. Rheumatol., 24, 9-14, 1997.
122. Thun, M. J., Manboodiri, M. M., and Heath, C. W. J., Aspirin use and reduced risk of fatal colon cancer, N. Engl. J. Med., 325, 1593-1596, 1991.
123. Greenberg, E. R., Baron, J. A., Freeman, D. H., Jr., Mandel, J. S., and Haile, R., Reduced risk of large-bowel adenoma among aspirin users. The Polyp Prevention Study Group, J. Natl. Cancer Inst., 85, 912-916, 1993.
124. Logan, R. F., Little, J., Hawtin, P. G., and Hardcastle, J. D., Effect of aspirin and nonsteroidal antiinflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme, Br. J. Med., 307, 285-289, 1993.
125. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhause, G. J., Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis, N. Engl. J. Med., 1993; 328: 1313-1316.
126. Smalley, W. and DuBois, R. N., Colorectal cancer and nonsteroidal antiinflammatory drugs, Adv. Pharmacol., 39, 1-20, 1997.
127. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N., Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology, 107, 1183-1188, 1994.
128. Kargman, S. L., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., and Jothy, S., Expression of prostaglandin G/H synthase-1 and -2 in human colon cancer, Cancer Res., 55, 2556-2559, 1995.
129. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asia, K., Kimura, S., Kato, H., Kondo, M., and Hla, T., Expression of cyclooxygenase-1 and -2 in human colorectal cancer, Cancer Res., 55, 3785-3789, 1995.
130. DuBois, R. N., Radhika, A., Reddy, B. S., and Etingh, A. J., Increased cyclooxygenase-2 levels in carcinogen-induced rat colonie tumors, Gastroenterology, 110, 1259-1262, 1996.
131. Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D., and DuBois, R. N., Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2, J. Clin. Invest., 99, 2254-2259, 1997.
132. Kawamori, T., Rao, C. V., Seibert, K., and Reddy, B. S., Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis, Cancer Res., 58, 409-412, 1998.
133. Tsujii, M. and DuBois, R. N., Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2, Cell, 83, 493-501, 1995.
134. Dubois, R. N., Shao, J. Y., Tsujii, M., Sheng, H. M., and Beauchamp, R. D., G(1) delay in cells overexpressing prostaglandin endoperoxidase synthase-2, Cancer Res., 56, 733-737, 1996.
135. Coffey, R. J., Hawkey, C. J., Damstrup, L., Graves-Deal, R., Daniel, V. C., Dempsey, P. J., Chinery, R., Kirkland, S. C., DuBois, R. N., Jetton, T. L., and Morrow, J. D., Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells, Proc. Natl. Acad. Sci. U.S.A., 94, 657-662, 1997.
136. Tsujii, M., Kawano, S., and DuBois, R. N., Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential, Proc. Natl. Acad. Sci. U.S.A., 94, 3336-3340, 1997.
137. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N., Cyclooxygenase regulates angiogenesis induced by colon cancer cells, Cell, 93, 705-716, 1998.
138. Mizuno, H., Sakamoto, C., Matsuda, K., Wada, K., and Uchida, T., Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice, Gasteroenterology, 112, 387-397, 1997.
139. Ristimäki, A., Honkanen, N., Jänkälä, H., Sipponen, P., and Härkönen, M., Expression of cyclooxygenase-2 in human gastric carcinoma, Cancer Res., 57, 1276-1280, 1997.
140. Parett, M. L., Harris, R. E., Joarder, F. S., Ross, M. S., Clausen, K. P., and Robertson, F. M., Cyclooxygenase-2 gene expression in human breast cancer, Int. J. Oncol., 10, 503-507, 1997.
141. Buckman, S. Y., Greshman, A., Hale, P., Hruza, G., Anast, J., Masferrer, J., and Pentland, A. P., COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer, Carcinogenesis, 19, 723-729, 1998.
142. Narko, K., Ristimäki, A., MacPhee, M., Smith, E., Haudenschild, C. C., and Hla, T., Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression, J. Biol. Chem., 272, 21455-21460, 1997.
143. Vane, J. R., Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs, Nature, 231, 232-235, 1971.
144. DeWitt, D. L., El-Harith, E. A., Kraemer, S. A., Andrews, M. J., Yao, E. F., Armstrong, R. L., and Smith, W. L., The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxidase syntheses, J. Biol. Chem., 265, 5192-5198, 1990.
145. Engelhardt, G., Homma, D., Schlegel, K., Utzmann, R., and Schnitzler, C., Antiinflammatory, analgesic, antipyretic, and related properties of meloxicam, a new nonsteroidal antiinflammatory agent with favorable gastrointestinal tolerance, Inflamm. Res., 44, 423-433, 1995.
146. Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., and Vane, J. R., Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase, Proc. Natl. Acad. Sci. U.S.A., 90, 11693-11697, 1993.
147. Holtzman, M. J., Turk, J., and Shornick, L. P., Identification of a phamacologically distinct prostaglandin H synthase in cultured epithelial cells, J. Biol. Chem., 267, 21438-21445, 1992.
148. Schror, K., Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis, Sem. Thromb. Hemostasis, 23, 349-356, 1997.
149. Futaki, N., Yoshikawa, K., Hamasaka, Y., Arai, I., Higuchi, S., Iizuka, H., and Otomo, S., NS-398, a novel nonsteroidal antiinflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions, Gen. Pharmacol., 24, 105-110, 1993.
150. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., and Otomo, S., NS-398, a new antiinflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro, Prostaglandins, 47, 55-59, 1994.
151. Cryer, B. and Feldman, M., Cyclooxgyenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal antiinflammatory drugs, Am. J. Med., 104, 413-421, 1998.
152. Furst, D. E., Meloxicam: selective COX-2 inhibition in clinical practice, Sem. Arthr. Rheumat., 26 (Suppl. 1), 21-27, 1997.
153. Pennisi, E., Building a better aspirin, Science, 280, 1191-1192, 1998.
154. Kalgutar, A. S., Crews, B. C., Rowlinson, S. W., Garner, C., Seibert, K., and Marnett, L. J., Aspirin-like molecules that covalently inactivate cyclooxygenase-2, Science, 280, 1268-1270, 1998.
155. Frölich, J. C., A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes, Trends Pharmocol. Sci., 18, 30-34, 1997.
156. Namba, T., Sugimoto, Y., Negishi, M., Irie, A., Ushikubi, F., Kakizuka, A., Ito, S., Ichikawa, A., and Narumiya, S., Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity, Nature, 365, 166-170, 1993.
157. Narumiya, S., Prostanoid receptors and signal transduction, Prog. Brain Res., 113, 231-241, 1996.
158. Ushikubi, F., Hirata, M., and Narumiya, S., Molecular biology of prostanoid receptors; an overview, J. Lipid Mediat. Cell Signal., 12, 343-359, 1995.
159. Breyer, M. D., Jacobson, H. R., and Breyer, R. M., Functional and molecular aspects of renal prostaglandin receptors, J. Am. Soc. Nephrol., 7, 8-17, 1996.
160. Mangelsdorf, D. J. and Evans, R. M., The RXR heterodimers and orphan receptors, Cell, 83, 841-850, 1995.
161. 2 is a ligand for the adipocyte determination factor PPARγ, Cell, 83, 803-812, 1995.
162. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation, Cell, 85, 813-819, 1995.
163. 2 in human pl-21 myeloid leukemia and RC-K8 pre-B lymphoma cells, Prostaglandins, 52, 143-156, 1996.
164. 2, Prostaglandins, 51, 413-425, 1996.
165. 2 is likely antigen-presenting cells, J. Immunol., 143, 2982-2989, 1989.
166. Jiang, C., Ting, A. T., and Seed, B., PPAR-γ agonists inhibit production of monocyte inflammatory cytokines, Nature, 391, 82-86, 1998.
167. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., and Glass, C. K., The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation, Nature, 391, 79-82, 1998.
168. Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., and Kleiwer, S. A., Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other nonsteroidal antiinflammatory drugs, J. Biol. Chem., 272, 3406-3410, 1997.
169. Breder, C. D., Smith, W. L., Raz, A., Masferrer, J., Seibert, K., Needleman, P., and Saper, C. B., Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain, J. Comp. Neurol., 322, 409-438, 1992.
170. Tsubokura, S., Watanabe, Y., Ehara, H., Imamura, K., Sugimoto, O., Kagamiyama, H., Yamamoto, S., and Hayaishi, O., Localization of prostaglandin endoperoxide synthase in neurons and glia in monkey brain, Brain Res., 543, 15-24, 1991.
171. Kawasaki, M., Yoshihara, Y., Yamaji, M., and Watanabe, Y., Expression of prostaglandin endoperoxide synthase in rat brain, Mol. Brain Res., 19, 39-46, 1993.
172. Li, S.-R., Wu, K. K., Anggard, E., and Ferns, G., Localization of prostaglandin G/H synthase gene expression in rat brain by in situ hybridization, Biol. Signals, 2, 77-83, 1994.
173. Norton, J. L., Adamsom, S. L., Bocking, A. D., and Han, V. K. M., Prostaglandin-H synthase-1 (PGHS-1) gene is expressed in specific neurons of the brain of the late gestation ovine fetus, Dev. Brain Res., 95, 79-96, 1996.
174. Kaplan, M. D., Olschowka, J. A., and O'Banion, M. K., Cyclooxygenase-1 behaves as a delayed response gene in PC12 cells differentiated by nerve growth factor, J. Biol. Chem., 272, 18534-18537, 1997.
175. Breder, C. D., DeWitt, D., and Kraig, R. P., Characterization of inducible cyclooxygenase in rat brain, J. Comp. Neurol., 355, 296-315, 1995.
176. Kaufmann, W. E., Worley, P. F., Taylor, C. V., Bremer, M., and Isakson, P. C., Cyclooxygenase-2 expression during rat neocortical development and in Rett syndrome, Brain Dev., 19, 25-34, 1997.
177. Peri, K. G., Hardy, P., Li, D. Y., Varma, D. R., and Chemtob, S., Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn, J. Biol. Chem., 270, 24615-24620, 1995.
178. Thore, C. R., Beasley, T. C., and Busija, D. W., In vitro and in vivo localization of prostaglandin H synthase in fetal sheep neurons, Neurosci. Lett., 242, 29-32, 1998.
179. Chen, J., Marsh, T., Zhang, J. S., and Graham, S. H., Expression of cyclooxygenase-2 in rat brain following kainate treatment, Neuroreport, 6, 245-248, 1995.
180. Marcheselli, V. L. and Bazan, N. G., Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus, J. Biol. Chem., 271, 24794-24799, 1996.
181. Tocco, G., Freiremoar, J., Schreiber, S. S., Sakhi, S. H., Aisen, P. S., and Pasinetti, G. M., Maturational regulation and regional induction of cyclooxygenase-2 in rat brain - implications for Alzheimer's disease, Exp. Neurol., 144, 339-349, 1997.
182. Adams, J., Collaço-Moraes, Y., and de Belleroche, J., Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation, J. Neurochem., 66, 6-13, 1996.
183. McCown, T. J., Knapp, D. J., and Crews, F. T., Inferior collicular seizure generalization produces site-selective cortical induction of cyclooxygenase 2 (COX-2), Brain Res., 767, 370-374, 1997.
184. Akins, P. T., Liu, P. K., and Hsu, C. Y., Immediate early gene expression in response to cerebral ischemia: friend or foe?, Stroke, 27, 1682-1687, 1996.
185. Dragunow, M. and Preston, K., The role of inducible transcription factors in apoptotic nerve cell death, Brain Res. Rev., 21, 1-28, 1995.
186. Collaço-Moraes, Y., Aspey, B., Harrison, M., and de Belleroche, J., Cyclooxygenase-2 messenger RNA induction in focal cerebral ischemia, J. Cereb. Blood Flow Met., 16, 1366-1372, 1996.
187. Sairanen, T., Ristimäki, A., Karjalainen-Lindsberg, M.-L., Paetau, A., Kaste, M., and Lindsberg, P. J., Cyclooxygenase-2 is induced globally in infarcted human brain, Ann. Neurol., 43, 738-747, 1998.
188. 2, Proc. Natl. Acad. Sci. U.S.A., 94, 6500-6505, 1997.
189. Nogawa, S., Zhang, F., Ross, M. E., and Iadecola, C., Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage, J. Neurosci., 17, 2746-2755, 1997.
190. Sanz, O., Estrada, A., Ferrer, I., and Planas, A. M., Differential cellular distribution and dynamics of HSP70, cyclooxygenase-2 and c-FOS in the rat brain after transient focal ischemia or kainic acid, Neuroscience, 80, 221-232, 1997.
191. 2 in the hypoxic-ischemic brain: role in neuronal death or survival?, Mol. Brain Res., 50, 165-170, 1997.
192. Graham, S. H., Nakayama, M., Zhu, R., and Chen, J., Cyclooxygenase 2 and the pathogenesis of delayed neuronal death after global ischemia, Neurology, 46, A408, 1996.
193. Ohtsuki, T., Kitagawa, K., Yamagata, K., Mandai, K., Mabuchi, T., Matsushita, K., Yanagihara, T., and Matsumoto, M., Induction of cyclooxygenase-2 mRNA in gerbil hippocampal neurons after transient forebrain ischemia, Brain Res., 736, 353-356, 1996.
194. Holtz, M. L., Kindy, M. S., Craddock, S., Moore, R. W., and Pettigrew, L. C., Induction of PGH synthase and c-fos mRNA during early reperfusion of ischemic rat brain, Mol. Brain Res., 35, 339-343, 1996.
195. Graham, S. H., Kawaguchi, K., Zhu, L., and Chen, J., Cyclooxygenase-2 is induced in rat brain after kainate induced seizures and promotes neuronal death in CA3 hippocampus, Soc. Neurosci. Abstr., 22, 2088, 1996.
196. Ho, L., Osaka, H., Aisen, P. S., and Pasinetti, G. M., Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death, J. Neuroimmunol., 89, 142-149, 1998.
197. Bagetta, G., Corasaniti, M. T., Paoletti, A. M., Berliocchi, L., Nisticò, R., Giammarioli, A. M., Malorni, W., and Finazzi-Agrò, A., HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cyclo-oxygnenase type 2 (COX-2), Biochem. Biophys. Res. Comm., 244, 819-824, 1998.
198. Hewett, S. J. and Hewett, J. A., COX-2 contributes to NMDA-induced neuronal death in cortical cell cultures, Soc. Neurosci. Abstr., 23, 1666, 1997.
199. Normandin, M., Gagné, J., Bernard, J., Élie, R., Miceli, D., Baudry, M., and Massicotte, G., Involvement of the 12-lipoxygenase pathway of arachidonic acid metabolism in homosynaptic long-term depression of the rat hippocampus, Brain Res., 730, 40-46, 1996.
200. Lerea, L. S. and McNamara, J. O., Ionotropic glutamate receptor subtypes activate c-fos transcription by distinct calcium requiring intracellular pathways, Neuron, 10, 31-41, 1993.
201. 2α is required for NMDA receptor-mediated induction of c-fos mRNA in dentate gyrus neurons, J. Neurosci., 17, 117-124, 1997.
202. 2-requiring intracellular signaling pathways, Mol. Pharmacol., 47, 1119-1125, 1995.
203. Kreutzberg, G. W., Microglia: a sensor for pathological events in the CNS, Trends Neurosci., 19, 312-318, 1996.
204. Moore, S. and Thanos, S., The concept of microglia in relation to central nervous system disease and regeneration, Prog. Neurobiol., 48, 441-460, 1996.
205. Zielasek, J. and Hartung, H. P., Molecular mechanisms of microglial activation, Adv. Neuroimmunol., 6, 191-220, 1996.
206. Gebicke-Haerter, P. J., Bauer, J., Schobert, A., and Northoff, H., Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells, J. Neurosci., 9, 183-194, 1989.
207. Minghetti, L. and Levi, G., Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures, J. Neurochem., 65, 2690-2698, 1995.
208. O'Banion, M. K., Dusel, J. C., Chang, J. W., Kaplan, M. D., and Coleman, P. D., Interleukin-1β induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures, J. Neurochem., 66, 2532-2540, 1996.
209. Slepko, N., Minghetti, L., Polazzi, E., Nicolini, A., and Levi, G., Reorientation of prostanoid production accompanies "activation" of adult microglial cells in culture, J. Neurosci. Res., 49, 292-300, 1997.
210. Bauer, M. K. A., Lieb, K., Schulzeostohoff, K., Berger, M., Gebicke-Haerter, P. J., Bauer, J., and Fiebich, B. L., Expression and regulation of cyclooxygenase-2 in rat microglia, Eur. J. Biochem., 243, 726-731, 1997.
211. 2a-receptors, Glia, 18, 152-160, 1996.
212. 2α production in human microglial cells but not in astrocytes, J. Immunol., 157, 2129-2135, 1996.
213. 2, cyclic AMP, and nonsteroidal antiinflammatory drugs, Eur. J. Neurosci., 9, 934-940, 1997.
214. 2 synthesis by transforming growth factor-β1 and interleukin-10 in activated microglial cultures, J. Neuroimmunol., 82, 31-39, 1998.
215. Minghetti, L., Polazzi, E., Nicolini, A., Créminon, C., and Levi, G., Interferon gamma and nitric oxide downregulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression, J. Neurochem., 66, 1963-1970, 1996.
216. 2 and by cyclooxygenase inhibitors, Glia, 19, 152-160, 1997.
217. Minghetti, L. and Levi, G., Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide, Prog. Neurobiol., 54, 99-125, 1997.
218. Lee, S. H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., and Hwang, D., Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide, J. Biol. Chem., 267, 25934-25938, 1992.
219. O'Banion, M. K. and Olschowka, J. A., Localization and distribution of cyclooxygenase-2 in brain tissue by immunocytochemistry, in Prostaglandin Protocols, Lianos, E. A., Ed., Humana Press Inc., Totowa, NJ, 1999, in press.
220. Caggiano, A. O. and Kraig, R. P., Eicosanoids and nitric oxide influence induction of reactive gliosis from spreading depression in microglia but not astrocytes, J. Comp. Neurol, 369, 93-108, 1996.
221. Ridet, J. L., Malhortra, S. K., Privat, A., and Gage, F. H., Reactive astrocytes: cellular and molecular cues to biological function, Trends Neurosci., 20, 570-577, 1997.
222. Giulian, D., Woodward, J., Young, D. G., Krebs, J. F., and Lachman, L. B., Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization, J. Neurosci., 8, 2485-2490, 1988.
223. Jeremy, J., Murphy, S., Morrow, C., Pearce, B., and Dandona, P., Phorbol ester stimulation of prostanoid synthesis by cultured astrocytes, Brain Res., 419, 364-368, 1987.
224. Sergei, A., Keller, M., and Hertting, G., Are cerebral prostanoids of astroglial origin? Studies of the prostanoid forming system in developing rat brain and primary cultures of rat astrocytes, Brain Res., 404, 113-120, 1987.
225. Hartung, H.-P., Schäfer, B., Heininger, K., and Toyka, K. V., Recombinant interleukin-1β stimulates eicosanoid production in rat primary culture astrocytes, Brain Res., 489, 113-119, 1989.
226. 2 in rat astrocyte cultures: modulatory effect of neuropeptides, Endocrinology, 124, 3125-3127, 1989.
227. O'Banion, M. K., Dusel, J. C., Chang, J. W., and Coleman, P. D., Interleukin-1β induction of prostaglandin G/H synthase-2 (PGHS-2) and inducible nitric oxide synthase (iNOS) in cultured murine glial cells, Soc. Neurosci. Abstr., 20, 1496, 1994.
228. Nam, M. J., Thore, C., and Busija, D., Effects of protein kinase C activation on prostaglandin production and cyclooxygenase mRNA levels in ovine astroglia, Prostaglandins, 51, 203-213, 1996.
229. O'Banion, M. K., Chang, J. W., and Coleman, P. D., Decreased expression of prostaglandin G/H synthase (PGHS-2) in Alzheimer' s disease brain, Adv. Exp. Med., 407, 171-177, 1997.
230. Thore, C. R., Nam, M. J., and Busija, D. W., Immunofluorescent localization of constitutive and inducible prostaglandin H synthase in ovine astroglia, J. Comp. Neurol., 367, 1-9, 1996.
231. Lim, R. W., Varnum, B. C., and Herschman, H. R., Cloning of tetradecanoyl phorbol ester-induced 'primary response' sequences and their expression in density-arrested Swiss 3T3 cells and a TPA nonproliferative variant, Oncogene, 1, 263-270, 1987.
232. Arenander, A. T., Lim, R. W., Varnum, B. C., Cole, R., de Vellis, J., and Herschman, H. R., TIS gene expression in cultured rat astrocytes: induction by mitogens and stellation agents, J. Neurosci. Res., 23, 247-256, 1989.
233. Molina-Holgado, F., Lledó, A., and Guaza, C., Evidence for cyclooxygenase activation by nitric oxide in astrocytes, Glia, 15, 167-172, 1995.
234. Chang, J. W., Coleman, P. D., and O'Banion, M. K., Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease, Neurobiol. Aging, 17, 801-808, 1996.
235. 2 and cyclooxygenase-2 in the hippocampus after kainate lesions, Brain Res., 788, 223-231, 1998.
236. 2 after transient global forebrain ischemia in the rat, Stroke, 27, 527-535, 1996.
237. 2 receptor EPS in the rat lumbar spinal cord, J. Neuroimmunol., 89, 26-34, 1998.
238. 2 production, Glia, 21, 183-193, 1997.
239. 2, Brain Res., 777, 210-218, 1997.
240. Ma, Y. J., Berg-von der Emde, K., Rage, F., Wetsel, W. C., and Ojeda, S. R., Hypothalamic astrocytes respond to transforming growth factor-α with the secretion of neuroactive substances that stimulate the release of leutinizing hormone-releasing hormone, Endocrinology, 138, 19-25, 1997.
241. Elmquist, J. K., Scammell, T. E., and Saper, C. B., Mechanisms of CNS response to systemic immune challenge - the febrile response, Trends Neurosci., 20, 565-570, 1997.
242. Cao, C., Matsumura, K., Yamagata, K., and Watanabe, Y., Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response, Brain Res., 697, 187-196, 1995.
243. Breder, C. D. and Saper, C. B., Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccharide, Brain Res., 713, 64-69, 1996.
244. Lacroix, S. and Rivest, S., Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain, J. Neurochem., 70, 452-466, 1998.
245. Cao, C., Matsumura, K., Yamagata, K., and Watanabe, Y., Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1β: a possible site of prostaglandin synthesis responsible for fever, Brain Res., 733, 263-272, 1996.
246. Matsumura, K., Cao, C., Ozaki, M., Morii, H., Nakadate, K., and Watanabe, Y., Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocytochemical studies, J. Neurosci., 18, 6279-6289, 1998.
247. Quan, N., Whiteside, M., and Herkenham, M., Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide, Brain Res., 802, 189-197, 1998.
248. Parfenova, H., Eidson, T. H., and Leffler, C. W., Upregulation of COX-2 in cerebral microvascular endothelial cells by smooth muscle cell signals, Am. J. Physiol., 273, C277-C288, 1997.
249. Moore, S. A., Yoder, E., Rich, G., Hilfers, M., and Albright, J., Regulation of cerebrovascular cyclooxygenase-2 by pro- and antiinflammatory cytokines, in Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Related Diseases, Honn, K. V., Nigam, S., Marnett, L. J., and Dennis, E., Eds., Plenum, New York, in press.
250. Elmquist, J. K., Breder, C. D., Sherin, J. E., Scammell, T. E., Hickey, W. F., DeWitt, D., and Saper, C. B., Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages, J. Comp. Neurol, 381, 119-129, 1997.
251. Cao, C., Matsumura, K., Yamagata, K., and Watanabe, Y., Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain, Am. J. Physiol., 272, R1712-R1725, 1997.
252. Chan, C.-C., Panneton, M., Taylor, A. M., Therien, M., and Rodger, I. W., A selective inhibitor of cyclooxygenase-2 reverses endotoxin-induced pyretic responses in non-human primates, Eur. J. Pharmacol., 327, 221-225, 1997.
253. Taniguchi, Y., Yokoyama, K., Inui, K., Deguchi, Y., Furukawa, K., and Noda, K., Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide, Eur. J. Pharmacol., 330, 221-229, 1997.
254. 2 type, J. Neuroimmunol., 70, 163-179, 1996.
255. Niimi, M., Sato, M., Wada, Y., Takahara, J., and Kawanishi, K., Effect of central and continuous intravenous injection of interleukin-1β on brain c-fos expression in the rat: involvement of prostaglandins, Neuroimmunomodulation, 3, 87-92, 1996.
256. Ericsson, A., Arias, C., and Sawchenko, P. E., Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1, J. Neurosci., 17, 7166-7179, 1997.
257. Lacroix, S. and Rivest, S., Functional circuitry in the brain of immune-challenged rats: partial involvement of prostaglandins, J. Comp. Neurol., 387, 307-324, 1997.
258. Navarra, P., Tsagarakis, S., Faria, M. S., Rees, L. H., Besser, M., and Grossman, A. B., Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway, Endocrinology, 128, 37-44, 1991.
259. Spangelo, B. L., Jarvis, W. D., Judd, A. M., and MacLeod, R. M., Induction of interleukin-6 release by interleukin-1 in rat anterior pituitary cells in vitro: evidence for an eicosanoid-dependent mechanism, Endocrinology, 129, 2886-2894, 1991.
260. Rivest, S. and Rivier, C., Centrally injected interleukin-1 beta inhibits the hypothalamic LHRH secretion and circulating LH levels via prostaglandins in rats, J. Neuroendocrinol., 5, 445-450, 1993.
261. Turnbull, A. V. and Rivier, C., Corticotropin-releasing factor, vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local inflammation in the rat, Endocrinology, 137, 455-463, 1996.
262. 2, Prostag. Leukotr. Ess. Fatty Acids, 47, 105-110, 1992.
263. Ting, P., Indomethacin attenuates early postischemic vasogenic edema and cerebral injury, Adv. Neurol., 52, 119-126, 1990.
264. Zuckerman, S. L., Mirro, R., Armstead, W. M., Shibata, M. and Leffler, C. W., Indomethacin reduces ischemia-induced alteration of blood-brain barrier transport in piglets, Am. J. Physiol., 266, H2198-H2203, 1994.
265. Sharma, H. S., Westman, J., Cervos-Navarro, J., and Nyberg, F., Role of neurochemicals in brain edema and cell changes following hyperthermic brain injury in the rat, Acta Neurochirur. Suppl., 70, 269-274, 1997.
266. de Vries, H. E., Blom-Roosemalen, M. C. M., van Oosten, M., de Boer, A. G., van Berkel, T. J. C., Breimer, D. D., and Kuiper, J., The influence of cytokines on the integrity of the blood-brain barrier in vitro, J. Neuroimmunol., 64, 37-43, 1996.
267. Stanimirovic, D., Shapiro, A., Wong, J., Hutchison, J., and Durkin, J., The induction of ICAM-1 in human cerebromicrovascular endothelial cells (HCEC) by ischemia-like conditions promotes enhanced neutrophil/HCEC adhesion, J. Neuroimmunol., 76, 193-205, 1997.
268. Bronner, L. L., Kanter, D. S., and Manson, J. E., Primary prevention of stroke, N. Engl. J. Med., 333, 1392-1400, 1995.
269. Sasaki, T., Nakagomi, T., Kirino, T., Tamura, A., Noguchi, M., Saito, I., and Takakura, K., Indomethacin ameliorates ischemic neuronal damage in the gerbil hippocampal CA1 sector, Stroke, 19, 1399-1403, 1988.
270. Clemens, J. A., Ho, P. P. K., and Panetta, J. A., LY178002 reduces rat brain damage after transient global forebrain ischemia, Stroke, 22, 1048-1052, 1991.
271. Nakagomi, T., Sasaki, T., Kirino, T., Tamura, A., Noguchi, M., Saito, I. and Takakura, K., Effect of cyclooxygenase and lipoxygenase inhibitors on delayed neuronal death in the gerbil hippocampus, Stroke, 20, 925-929, 1989.
272. Patel, P. M., Drummond, J. C., Sano, T., Cole, D. J., Kalkman, C. J., and Yaksh, T. L., Effect of ibuprofen on regional eisosanoid production and neuronal injury after forebrain ischemia in rats, Brain Res., 614, 315-324, 1993.
273. Nakayama, M., Uchimura, K., Zhu, R. L., Nagayama, T., Rose, M. E., Stetler, R. A., Isakson, P. C., Chen, J., and Graham, S. H., Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia, Proc. Natl. Acad. Sci. U.S.A., 95, 10954-10959, 1998.
274. Huang, Z., Huang, P. L., Panahian, N., Dalkara, T., Fishman, M. C., and Moskowitz, M. A., Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase, Science, 265, 1883-1885, 1994.
275. Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., and Snyder, S. H., Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures, Proc. Natl. Acad. Sci. U.S.A., 88, 6368-6371, 1991.
276. Hewett, S. J., Csernansky, C. A., and Choi, D. W., Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS, Neuron, 13, 487-494, 1994.
277. Nogawa, S., Forster, C., Zhang, F., Nagayama, M., Ross, M. E., and Iadecola, C., Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia, Proc. Natl Acad. Sci. U.S.A., 95, 10966-10971, 1998.
278. Smeyne, R. J., Verdrell, M., Hayward, M., Baker, S. J., Miao, G. G., Schilling, K., Robertson, L. M., Curran, T., and Morgan, J. I., Continuous c-fos expression precedes programmed cell death in vivo, Nature, 363, 166-169, 1993.
279. Hafezi, F., Steinbach, J. P., Marti, A., Munz, K., Wang, Z.-Q., Wagner, E. F., Aguzzi, A., and Remé, C. E., The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo, Nature Med., 3, 346-349, 1997.
280. Estus, S., Zaks, W. J., Freeman, R. S., Gruda, M., Bravo, R., and Johnson, E. M. J., Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis, J. Cell Biol., 6, 1717-1727, 1994.
281. Freeman, R. S., Estus, S., and Johnson, E. M., Jr., Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death, Neuron, 12, 343-355, 1994.
282. Guégan, C., Levy, V., David, J.-P., Ajchenbaum-Cymbalista, F., and Sola, B., c-jun and cyclin D1 proteins as mediators of neuronal death after a focal ischaemic insult, Neuroreport, 8, 1003-1007, 1997.
283. Herrup, K. and Brusser, J. C., The induction of multiple cell cycle events precedes target-related neuronal death, Development, 121, 2385-2395, 1995.
284. D'Mello, S. R., Molecular regulation of neuronal apoptosis, Curr. Top. Dev. Biol., 39, 187-213, 1998.
285. Rothwell, N. J., Loddick, S. A., and Stroemer, P., Interleukins and cerebral ischemia, Int. Rev. Neurobiol., 40, 281-298, 1997.
286. Okamoto, H., Ito, O., Roman, R. J., and Hudetz, A. G., Role of inducible nitric oxide synthase and cyclooxygenase-2 in endotoxin-induced cerebral hyperemia, Stroke, 29, 1209-1218, 1998.
287. 2) protects rat cortical neurons in culture against hypoxia/reoxygenation and glutamate-induced injury, Neurosci. Lett., 160, 106-108, 1993.
288. Breitner, J. C. S., The role of antiinflammatory drugs in the prevention and treatment of Alzheimer's disease, Ann. Rev. Med., 47, 401-411, 1996.
289. Jenkinson, M. L., Bliss, M. R., Brain, A. T., and Scott, D. L., Rheumatoid arthritis and senile dementia of the Alzheimer's type, Br. J. Rheumatol., 28, 86-88, 1989.
290. McGeer, P. L., McGeer, E., Rogers, J., and Sibley, J., Antiinflammatory drugs and Alzheimer's disease, Lancet, 335, 1037, 1990.
291. Breitner, J. C. S., Welsh, K. A., Helms, M. J., Gaskell, P. C., Gau, B. A., Roses, A. D., Pericak-Vance, M. A., and Saunders, A. M., Delayed onset of Alzheimer's disease with nonsteroidal antiinflammatory and histamine H2 blocking drugs, Neurobiol. Aging, 16, 523-530, 1995.
292. Rich, J. B., Rasmusson, D. X., Folstein, M. F., Carson, K. A., Kawas, C., and Brandt, J., Nonsteroidal antiinflammatory drugs in Alzheimer's disease, Neurology, 1995; 45, 51-55, 1995.
293. McGeer, P. L., Schulzer, M., and McGeer, E. G., Arthritis and antiinflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiological studies, Neurology, 47, 425-432, 1996.
294. Stewart, W. F., Kawas, C., Corrada, M., and Metter, E. J., Risk of Alzheimer's disease and duration of NSAID use, Neurology, 48, 626-632, 1997.
295. Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L., McGeer, P. L., Kasznaik, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Willson, P., and Kogan, F., Clinical trial of indomethacin in Alzheimer's disease, Neurology, 43, 1609-1611, 1993.
296. McGeer, P. and McGeer, E., The inflammation response system of the brain: implications for therapy of Alzheimer and other neurodegenerative diseases, Brain Res. Rev., 21, 195-218, 1995.
297. Rogers, J. and O'Barr, S., Inflammatory mediators in Alzheimer's disease, in Molecular Mechanisms of Dementia, Wasco, W. and Tanzi, R. E., Eds., Humana Press, Inc., Totowa, NJ, 1997, 177-198.
298. Griffin, W. S. T., Sheng, J. G., and Mrak, R. E., Inflammatory pathways: implications in Alzheimer's disease, in Molecular Mechanisms of Dementia, Wasco, W. and Tanzi, R. E., Eds., Humana Press, Inc., Totowa, NJ, 1997, 169-176.
299. Cotman, C. W., Tenner, A. J., and Cummings, B. J., β-amyloid converts an acute phase injury response to chronic injury responses, Neurobiol. Aging, 17, 723-731, 1996.
300. Rogers, J., Webster, S., Lue, L.-F., Brachova, L., Civin, W. H., Emmerling, M., Shivers, B., Walker, D., and McGeer, P., Inflammation and Alzheimer's disease pathogenesis, Neurobiol. Aging, 17, 681-686, 1996.
301. Mackenzie, I. R. A. and Munoz, D. G., Nonsteroidal antiinflammatory drug use and Alzheimer-type pathology in aging, Neurology, 50, 986-990, 1998.
302. Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B. A., and Mucke, L., Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6, Proc. Natl. Acad. Sci. U.S.A., 90, 10061-10065, 1993.
303. Chiang, C. S., Stalder, A., Samimi, A., and Campbell, I. L., Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice, Dev. Neurosci., 16, 212-221, 1994.
304. Brett, F. M., Mizisin, A. P., Powell, H. C., and Campbell, I. L., Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes, J. Neuropath. Exp. Neurol., 54, 766-775, 1995.
305. Heyser, C. J., Masliah, E., Samimi, A., Campbell, I. L., and Gold, L. H., Progressive decline in avoidance learning paralleled by inflammatory neuro-degeneration in transgenic mice expressing interleukin-6 in the brain, Proc. Natl. Acad. Sci. U.S.A., 94, 1500-1505, 1997.
306. Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Volk, B., and Berger, M., Interleukin-6 and α2-macroglobulin indicate an acute phase state in Alzheimer's disease cortices, FEBS Lett., 285, 111-114, 1991.
307. Strauss, S., Bauer, J., Ganter, U., Jonas, U., Berger, M., and Volk, B., Detection of interleukin-6 and alpha-2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients, Lab. Invest., 66, 223-230, 1992.
308. Hüll, M., Strauss, S., Berger, M., Volk, B., and Bauer, J., Inflammatory mechanisms in Alzheimer's disease, Eur. Arch. Psych. Clin. Neurosci., 246, 124-128, 1996.
309. Dash, P. K. and Moore, A. N., Enhanced processing of APP induced by IL-1ß can be reduced by indomethacin and nordihydroguaiaretic acid, Biochem. Biophys. Res. Comm., 208, 542-548, 1995.
310. O'Banion, M. K., Coleman, P. D., and Callahan, L. M., Regional neuronal loss in aging and Alzheimer's disease: a brief review, Sem. Neurosci., 6, 307-314, 1994.
311. Anderson, A. J., Cummings, B. J., and Cotman, C. W., Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: association with pathology, Exp. Neurol., 125, 286-295, 1994.
312. Su, J. H., Deng, G. M., and Cotman, C. W., Bax protein expression is increased in Alzheimer's brain - correlations with DNA damage, Bcl-2 expression, and brain pathology, J. Neuropath. Exp. Neurol., 56, 86-93, 1997.
313. Kitamura, Y., Shimohama, S., Kamoshima, W., Ota, T., Matsuoka, Y., Nomura, Y., Smith, M. A., Perry, G., Whitehouse, P. J., and Taniguchi, T., Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, ICH-1, and CPP32, in Alzheimer's disease, Brain Res., 780, 260-269, 1998.
314. Busser, J., Geldmacher, D. S., and Herrup, K., Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain, J. Neurosci., 18, 2801-2807, 1998.
315. Smith, M. A., Richey-Harris, P. L., Sayre, L. M., Beckman, J. S., and Perry, G., Widespread peroxynitrite-mediated damage in Alzheimer's disease, J. Neurosci., 17, 2653-2657, 1997.
316. Pasinetti, G. M. and Aisen, P. S., Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain, Neuroscience, 87, 319-324, 1998.
317. Iwamoto, N., Kobayashi, K., and Kosaka, K., The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients, J. Neurol., 236, 80-84, 1989.
318. Wong, P. T., McGeer, P. L., and McGeer, E. G., Decreased prostaglandin synthesis in postmortem cerebral cortex from patient's with Alzheimer's disease, Neurochem. Int., 21, 197-202, 1992.
319. Lukiw, W. J. and Bazan, N. G., Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex, J. Neurosci. Res., 50, 937-945, 1997.
320. Lukiw, W. J. and Bazan, N. G., Strong nuclear factor-κB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex, J. Neurosci. Res., 53, 583-592, 1998.
321. Oka, A. and Takashima, S., Induction of cyclooxygenase 2 in brains of patients with Down's syndrome and dementia of the Alzheimer's type, specific localization in affected neurones and axons, Neuroreport, 8, 1161-1164, 1997.
322. 2) immunoreactivity is elevated in Alzheimer's disease brain, Neurobiol. Dis., 3, 51-63, 1996.
323. Dray, A., Inflammatory mediators of pain, Br. J. Anaesth., 75, 125-131, 1995.
324. 2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture, J. Neurosci., 14, 4987-4997, 1994.
325. Nicol, G. D., Vasko, M. R., and Evans, A. R., Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons, J. Neurophysiol., 77, 167-176, 1997.
326. 2 production, J. Pharmacol. Exp. Therap., 283, 1069-1075, 1997.
327. Laird, J. M. A., Herrero, J. F., de la Rubia, P. G., and Cervero, F., Analgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats, central and peripheral components, Inflamm. Res., 46, 203-210, 1997.
328. Lawand, N. B., Willis, W. D., and Westlund, K. N., Blockade of joint inflammation and secondary hyperalgesia by L-NAME, a nitric oxide synthase inhibitor, Neuroreport, 8, 895-899, 1997.
329. Malmberg, A. B. and Yaksh, T. L., Antinociceptive actions of spinal nonsteroidal antiinflammatory agents on the formalin test in the rat, J. Pharmacol. Exp. Therap., 263, 136-146, 1992.
330. Malmberg, A. B. and Yaksh, T. L., Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition, Science, 257, 1276-1279, 1992.
331. 2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats, J. Neurosci., 15, 2768-2776, 1995.
332. 2 release, Eur. J. Pharmacol., 331, 155-160, 1997.
333. Yamamoto, T. and Nozaki-Taguchi, N., Analysis of the roles of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission, in Proc. 8th World Congress on Pain, Jensen, T. S., Turner, J. A., and Wiesenfeld-Hallin, Z., Eds., IASP Press, Seattle, WA, 1997, 303-312.
334. Yamamoto, T. and Nozaki-Taguchi, N., Role of spinal cyclooxygenase (COX)-2 on thermal hyperalgesia evoked by carrageenan injection in the rat, Neuroreport, 8, 2179-2182, 1997.
335. Dirig, D. M., Isakson, P. C., and Yaksh, T. L., Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats, J. Pharmacol. Exp. Therap., 285, 1031-1038, 1998.
336. Beiche, F., Scheuerer, S., Brune, K., Geisslinger, G., and Goppelt-Struebe, M., Upregulation of cyclo-oxgyenase-2 mRNA in the rat spinal cord following peripheral inflammation, FEBS Lett., 390, 165-169, 1996.
337. Hay, C. and de Belleroche, J., Carrageenan-induced hyperalgesia is associated with increased cyclo-oxygenase-2 expression in spinal cord, Neuroreport, 8, 1249-1251, 1997.
338. Ichitani, Y., Tiejun, S., Haeggstrom, J. Z., Samuelsson, B., and Hökfelt, T., Increased levels of cyclooxygenase-2 mRNA in the rat spinal cord after peripheral inflammation, an in situ hybridization study, Neuroreport, 8, 2949-2952, 1997.
339. Willingale, H. L., Gardiner, N. J., Mclymont, N., Giblett, S., and Grubb, B. D., Prostanoids synthesized by cyclooxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability, Br. J. Pharmacol., 122, 1593-1604, 1997.
340. Kusuhara, H., Fukunari, A., Matsuyuki, H., and Okumoto, T., Principal involvement of cyclooxygenase-1-derived prostaglandins in the c-fos expression of the rat hind brain following visceral stimulation with acetic acid, Mol. Brain Res., 52, 151-156, 1997.
341. Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., Ueno, A., Oh-ishi, S., and Narumiya, S., Altered pain perception and inflammatory response in mice lacking prostacyclin receptor, Nature, 388, 678-682, 1997.
342. Griffin, D. E., Wesselingh, S. L., and McArthur, J. C., Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia, Ann. Neurol., 35, 592-597, 1994.
343. Bo, L., Dawson, T. M., Wesselingh, S., Mork, S., Choi, S., Kong, P. A., Hanley, D., and Trapp, B. D., Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains, Ann. Neurol., 36, 778-786, 1994.
344. Parkinson, J. F., Mitrovic, B., and Merrill, J. E., The role of nitric oxide in multiple sclerosis, J. Mol. Med., 75, 174-186, 1997.
345. Bolton, C., Gordon, D., and Turk, J. L., A longitudinal study of the prostaglandin content of central nervous system tissues from guinea pigs with acute EAE, Int. J. Immunopharmacol., 6, 155-161, 1984.
346. Bolton, C., Parker, D., McLeod, J., and Turk, J. L., A study of the prostaglandin and thromboxane content of the central nervous system tissues with the development of chronic relapsing allergic encephalomyelitis, J. Neuroimmunol., 10, 201-206, 1986.
347. Mertin, J. and Stackpoole, A., Anti-PGE antibodies inhibit in vivo development of cell-mediated immunity, Nature, 194, 456-458, 1981.
348. Weber, F., Meyermann, R., and Hempel, K., Experimental allergic encephalomyelitis-prophylactic and therapeutic treatment with the cyclooxygenase inhibitor piroxicam (Feldene), Int. Arch. Allergy Appl. Immunol., 95, 136-141, 1991.
349. Hastings, T. G., Enzymatic oxidation of dopamine, the role of prostaglandin H synthase, J. Neurochem., 64, 919-924, 1995.
350. Mattammal, M. B., Strong, R., Lakshmi, V. M., Chung, H. D., and Stephenson, A. H., Prostaglandin H synthetase-mediated metabolism of dopamine, implication for Parkinson's disease, J. Neurochem., 64, 1645-1654, 1995.
351. Jenner, P. and Olanow, C. W., Oxidative stress and the pathogenesis of Parkinson's disease, Neurology, 47 (Suppl. 6), S161-S170, 1996.
352. Laruitzen, M., Pathophysiology of the migraine aura. The spreading depression theory, Brain, 117, 199-210, 1994.
353. Sandler, M., Migraine to the year 2000, Cephalagia, 15, 259-264, 1995.
354. Crofford, L. J., COX-1 and COX-2 tissue expression, implications and predictions, J. Rheumatol., 24, 15-19, 1997.